{
  "ticker": "REGN",
  "year": 2024,
  "quarter": 4,
  "last_updated": "2025-04-19T08:57:46.400210",
  "count": 24,
  "transactions": [
    {
      "id": 228266,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-12-16",
      "transaction_shares": "304",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "48829"
    },
    {
      "id": 228269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-12-16",
      "transaction_shares": "1054",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "49074"
    },
    {
      "id": 228284,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-12-16",
      "transaction_shares": "702",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "30075"
    },
    {
      "id": 228286,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-12-16",
      "transaction_shares": "969",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "34792"
    },
    {
      "id": 228297,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-12-16",
      "transaction_shares": "759",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "14230"
    },
    {
      "id": 228312,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-12-16",
      "transaction_shares": "298",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "4664"
    },
    {
      "id": 228349,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-12-16",
      "transaction_shares": "491",
      "transaction_price": "730.81",
      "transaction_type": "F",
      "shares_after_transaction": "16265"
    },
    {
      "id": 228328,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-12-09",
      "transaction_shares": "466",
      "transaction_price": "787.0",
      "transaction_type": "F",
      "shares_after_transaction": "49133"
    },
    {
      "id": 228274,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2591",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "17896"
    },
    {
      "id": 228279,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2024-12-06",
      "transaction_shares": "907",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "5111"
    },
    {
      "id": 228282,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2332",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "15263"
    },
    {
      "id": 228306,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-12-06",
      "transaction_shares": "3499",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "36253"
    },
    {
      "id": 228315,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-12-06",
      "transaction_shares": "2332",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "31269"
    },
    {
      "id": 228320,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-12-06",
      "transaction_shares": "3499",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "50620"
    },
    {
      "id": 195404,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-11-08",
      "transaction_shares": "1185",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "47121"
    },
    {
      "id": 228291,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-11-08",
      "transaction_shares": "1185",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "47121"
    },
    {
      "id": 195453,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-11-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 228346,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-11-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 164790,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-01",
      "transaction_shares": "3",
      "transaction_price": "1041.35",
      "transaction_type": "S",
      "shares_after_transaction": "17679"
    },
    {
      "id": 164796,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-10-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 195393,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-01",
      "transaction_shares": "3",
      "transaction_price": "1041.35",
      "transaction_type": "S",
      "shares_after_transaction": "17679"
    },
    {
      "id": 195399,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-10-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    },
    {
      "id": 228276,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-01",
      "transaction_shares": "3",
      "transaction_price": "1041.35",
      "transaction_type": "S",
      "shares_after_transaction": "17679"
    },
    {
      "id": 228285,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-10-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "13931"
    }
  ]
}